Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Evaluation of paraoxonase activity in patients with mixed connective tissue disease.

Bodolay E, Seres I, Szodoray P, Csípo I, Jakab Z, Vegh J, Szilagyi A, Szegedi G, Paragh G.

J Rheumatol. 2008 Feb;35(2):237-43. Epub 2007 Dec 15.

PMID:
18085736
2.

Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet.

Schulpis KH, Bartzeliotou A, Tsakiris S, Gounaris A, Papassotiriou I.

Eur J Clin Nutr. 2007 Jun;61(6):803-8. Epub 2007 Jan 3.

PMID:
17203019
3.

Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.

Gugliucci A, Mehlhaff K, Kinugasa E, Ogata H, Hermo R, Schulze J, Kimura S.

Clin Chim Acta. 2007 Feb;377(1-2):213-20. Epub 2006 Oct 11.

PMID:
17118352
4.

Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.

Kalmár T, Seres I, Balogh Z, Káplár M, Winkler G, Paragh G.

Diabetes Metab. 2005 Dec;31(6):574-80.

PMID:
16357806
5.

Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels.

Hajas A, Szodoray P, Barath S, Sipka S, Rezes S, Zeher M, Sziklai I, Szegedi G, Bodolay E.

J Rheumatol. 2009 Sep;36(9):1930-6. doi: 10.3899/jrheum.081314. Epub 2009 Aug 14.

PMID:
19684145
6.

Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women.

Kumru S, Aydin S, Gursu MF, Ozcan Z.

Eur J Obstet Gynecol Reprod Biol. 2004 Jun 15;114(2):177-81.

PMID:
15140512
7.

Serum paraoxonase levels in gastric cancer.

Akçay MN, Yilmaz I, Polat MF, Akçay G.

Hepatogastroenterology. 2003 Dec;50 Suppl 2:cclxxiii-cclxxv.

PMID:
15244199
8.

Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes.

Weijun G, Juming L, Guoqing Y, Jingtao D, Qinghua G, Yiming M, Changyu P.

Adv Ther. 2008 Sep;25(9):884-93. doi: 10.1007/s12325-008-0095-x.

PMID:
18781288
9.

Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease.

Bodolay E, Prohászka Z, Paragh G, Csipő I, Nagy G, Laczik R, Demeter N, Zöld E, Nakken B, Szegedi G, Szodoray P.

Immunol Res. 2014 Oct;60(1):50-9. doi: 10.1007/s12026-014-8552-x.

PMID:
24838263
10.

Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension.

Vegh J, Szodoray P, Kappelmayer J, Csipo I, Udvardy M, Lakos G, Aleksza M, Soltesz P, Szilágyi A, Zeher M, Szegedi G, Bodolay E.

Scand J Immunol. 2006 Jul;64(1):69-76.

11.

Assessment of serum paraoxonase and arylesterase activity in patients with endometrial cancer.

Arioz DT, Camuzcuoglu H, Toy H, Kurt S, Celik H, Erel O.

Eur J Gynaecol Oncol. 2009;30(6):679-82.

PMID:
20099504
12.

Association between PON 1 polymorphisms, PON activity and diabetes complications.

Hofer SE, Bennetts B, Chan AK, Holloway B, Karschimkus C, Jenkins AJ, Silink M, Donaghue KC.

J Diabetes Complications. 2006 Sep-Oct;20(5):322-8.

PMID:
16949520
14.
15.

Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities.

Schulpis KH, Barzeliotou A, Papadakis M, Rodolakis A, Antsaklis A, Papassotiriou I, Vlachos GD.

Clin Biochem. 2008 Mar;41(4-5):282-7. Epub 2007 Nov 7.

PMID:
18035058
16.

[Analysis of paraoxonase activity and lipid profile in lupus patients].

Kiss E, Seres I, Zsolt K, Tarr T, Csípo I, Szegedi G, Paragh G.

Orv Hetil. 2005 Nov 20;146(47):2395-402. Hungarian.

PMID:
16398152
17.

Paraoxonase and arylesterase activities in coronary artery disease.

Gur M, Aslan M, Yildiz A, Demirbag R, Yilmaz R, Selek S, Erel O, Ozdogru I.

Eur J Clin Invest. 2006 Nov;36(11):779-87.

PMID:
17032345
18.

Paraoxonase phenotype distribution in a healthy Iranian population.

Sepahvand F, Shafiei M, Ghaffari SM, Rahimi-Moghaddam P, Mahmoudian M.

Basic Clin Pharmacol Toxicol. 2007 Aug;101(2):104-7.

19.

Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.

Kiss E, Seres I, Tarr T, Kocsis Z, Szegedi G, Paragh G.

Ann N Y Acad Sci. 2007 Jun;1108:83-91.

PMID:
17893973
20.

Paraoxonase activity in glomerulonephritic patients.

Gullulu M, Kahvecioglu S, Dirican M, Akdag I, Ocak N, Demircan C, Dilek K, Ersoy A, Yavuz M, Yurtkuran M.

Ren Fail. 2007;29(4):433-9.

PMID:
17497465

Supplemental Content

Support Center